Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 785,100 shares, an increase of 32.5% from the January 15th total of 592,700 shares. Based on an average daily trading volume, of 436,600 shares, the short-interest ratio is presently 1.8 days. Approximately 7.9% of the company’s stock are sold short.
Institutional Trading of Jaguar Health
An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new stake in shares of Jaguar Health, Inc. (NASDAQ:JAGX – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health at the end of the most recent quarter. 12.04% of the stock is owned by hedge funds and other institutional investors.
Jaguar Health Price Performance
Shares of Jaguar Health stock traded up $0.04 during midday trading on Friday, hitting $0.90. The company’s stock had a trading volume of 358,118 shares, compared to its average volume of 329,583. The stock has a 50-day simple moving average of $0.95 and a 200-day simple moving average of $1.06. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. Jaguar Health has a 1-year low of $0.78 and a 1-year high of $21.60.
Jaguar Health Company Profile
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Featured Stories
- Five stocks we like better than Jaguar Health
- 10 Best Airline Stocks to Buy
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Buy P&G Now, Before It Sets A New All-Time High
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What is diluted earnings per share (Diluted EPS)?
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
